Article
PRKCH regulates hematopoietic stem cell function and predicts poor prognosis in acute myeloid leukemia.
Experimental hematology - 1 Sept 2017
Porter Shaina N, Magee Jeffrey A
Abstract excerpt
Acute myeloid leukemia (AML) cells often co-opt normal hematopoietic stem cell (HSC) programs to drive neoplastic proliferation, and HSC-related gene expression signatures have been identified as biomarkers for poor prognosis in AML patients. We sought to identify new regulators of HSCs and AML cells from previously published HSC and leukemia stem cell (LSC) gene expression signatures. We identified PRKCH...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
